Document is current
Any future updates will be listed below
-
Authors
Gomaa, Dalia A. https://orcid.org/0000-0002-0465-7777
El‑Haggar, Sahar M.
El-Shanshory, Mohamed R.
El-Razaky, Osama
El‑Afify, Dalia R.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05470998 at ClinicalTrials.govDocuments that mention this clinical trial
Clinical Study to Evaluate the Possible Efficacy and Safety of l-Arginine in Children with Sickle Cell Disease and Increased Tricuspid Regurgitant Jet Velocity: a Randomized Controlled Trial
https://doi.org/10.1007/s40272-025-00701-w
-
Funding
Funding for this research was provided by:
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank
Tanta University
- License Information
-
More Information
Article History
Accepted: 21 May 2025
First Online: 17 June 2025
Declarations
:
: Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
: Dalia A. Gomaa, Sahar M. El‑Haggar, Mohamed R. El-Shanshory, Osama El-Razaky, and Dalia R. El‑Afify declare that they have no potential conflicts of interest that might be relevant to the content of this manuscript.
: Data and materials are available upon request.
: The study followed the principles of the Declaration of Helsinki. The study protocol was accepted by the Research Ethics Committee of Tanta University in October 2021. Approval number: 34969 (10/21).
: Before participating in this study, written informed consent was obtained from all parents.
: Not applicable.
: Not applicable.
: All authors made major contributions to the trial design and manuscript. Patient enrollment was done by Dalia A. Gomaa and Mohamed R. El-Shanshory. Doppler echocardiography was performed by Osama El-Razaky. Laboratory analysis was performed by Dalia R. El‑Afify, and Dalia A. Gomaa. Statistical analysis was done by Sahar M. El‑Haggar and Dalia R. El‑Afify. The first draft of the manuscript was written by Dalia A. Gomaa. The final manuscript has been revised and approved by all authors
